Update on indices of disease activity in systemic sclerosis

被引:55
作者
Hudson, Marie [1 ]
Steele, Russell
Scleroderma, Canadian
Baron, Murray
机构
[1] McGill Univ, Div Rheumatol, Montreal, PQ, Canada
[2] SMBD Jewish Gen Hosp, Montreal, PQ, Canada
[3] McGill Univ, Dept Math & Stat, Montreal, PQ, Canada
基金
加拿大健康研究院;
关键词
disease activity; scleroderma; outcome measures; review;
D O I
10.1016/j.semarthrit.2007.01.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: An important barrier in the study of systemic sclerosis (SSc) is the difficulty in measuring disease activity. We reviewed the literature on currently available global measures of disease activity in SSc. Methods: The PubMed database (1950-2006) was searched for the key words "scleroderma" in conjunction with "disease activity" and then "disease severity." All relevant original and review articles in English and French were reviewed. Textbooks in rheumatology and pertinent secondary references were also reviewed. Results: There are currently 3 tools that are used to measure disease activity globally in SSc. Physician global assessments have been commonly used but have not been formally evaluated. The Valentini Disease Activity Index is a new measure that consists of 10 variables and a resulting score ranging from 0 to 10. It appears easy to use but lacks some face and content validity and responsiveness to change has yet to be demonstrated. The Medsger Disease Severity Scale measures disease severity in 9 organ systems. However, it assesses mostly damage and is difficult to score. Conclusions: There is currently no gold standard measure of disease activity in SSc. Given the need to measure disease activity in SSc and the limitations of the currently available instruments, efforts are ongoing to develop new ones. This represents a major challenge but one that remains particularly important to undertake. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:93 / 98
页数:6
相关论文
共 63 条
[1]  
*ARTHR SOC, SCLER
[2]  
Bombardieri S, 2003, CLIN EXP RHEUMATOL, V21, pS2
[3]   Systemic sclerosis: hypothesis-driven treatment strategies [J].
Charles, Christina ;
Clements, Philip ;
Furst, Daniel E. .
LANCET, 2006, 367 (9523) :1683-1691
[4]  
Clements Philip J., 1995, Current Opinion in Rheumatology, V7, P517
[5]  
Cohen J., 1988, POWERSTATISTICALSCIE, DOI 10.4324/9780203771587
[6]   Health-related quality of life measured by the Short Form 36 (SF-36) in systemic sclerosis:: correlations with indexes of disease activity and severity, disability, and depressive symptoms [J].
Danieli, E ;
Airò, P ;
Bettoni, L ;
Cinquini, M ;
Antonioli, CM ;
Cavazzana, I ;
Franceschini, F ;
Cattaneo, R .
CLINICAL RHEUMATOLOGY, 2005, 24 (01) :48-54
[7]   Health-related quality of life in systemic sclerosis as measured by the Short Form 36: Relationship with clinical and biologic markers [J].
Del Rosso, A ;
Boldrini, M ;
D'Agostino, D ;
Plinio, G ;
Placidi, A ;
Scarpato, A ;
Pignone, A ;
Generini, S ;
Konttinen, Y ;
Zoppi, M ;
Vlak, T ;
Placidi, G ;
Matucci-Cerinic, M .
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2004, 51 (03) :475-481
[8]   European multicentre study to define disease activity criteria for systemic sclerosis.: I.: Clinical and epidemiological features of 290 patients from 19 centres [J].
Della Rossa, A ;
Valentini, G ;
Bombardieri, S ;
Bencivelli, W ;
Silman, AJ ;
D'Angelo, S ;
Cerinic, MM ;
Belch, JF ;
Black, CM ;
Becvar, R ;
Bruhlman, P ;
Cozzi, F ;
Czirják, L ;
Drosos, AA ;
Dziankowska, B ;
Ferri, C ;
Gabrielli, A ;
Giacomelli, R ;
Hayem, G ;
Inanc, M ;
McHugh, NJ ;
Nielsen, H ;
Scorza, R ;
Tirri, E ;
van den Hoogen, FHJ ;
Vlachoyiannopoulos, PG .
ANNALS OF THE RHEUMATIC DISEASES, 2001, 60 (06) :585-591
[9]   THE AMERICAN-COLLEGE-OF-RHEUMATOLOGY PRELIMINARY CORE SET OF DISEASE-ACTIVITY MEASURES FOR RHEUMATOID-ARTHRITIS CLINICAL-TRIALS [J].
FELSON, DT ;
ANDERSON, JJ ;
BOERS, M ;
BOMBARDIER, C ;
CHERNOFF, M ;
FRIED, B ;
FURST, D ;
GOLDSMITH, C ;
KIESZAK, S ;
LIGHTFOOT, R ;
PAULUS, H ;
TUGWELL, P ;
WEINBLATT, M ;
WIDMARK, R ;
WILLIAMS, HJ ;
WOLFE, F .
ARTHRITIS AND RHEUMATISM, 1993, 36 (06) :729-740
[10]   EARLY PHENOTYPIC ACTIVATION OF CIRCULATING HELPER MEMORY T-CELLS IN SCLERODERMA - CORRELATION WITH DISEASE-ACTIVITY [J].
FIOCCO, U ;
ROSADA, M ;
COZZI, L ;
ORTOLANI, C ;
DESILVESTRO, G ;
RUFFATTI, A ;
COZZI, E ;
GALLO, C ;
TODESCO, S .
ANNALS OF THE RHEUMATIC DISEASES, 1993, 52 (04) :272-277